Cingulate (CING) stock: insider trades, news & valuation
Strong buyingShare price and insider trades
Cingulate insider trading at a glance (Oct 9, 2026): in the past 12 months, 4 insiders bought $647K and 0 sold $0 of CING stock on the open market, including a cluster buy that began Feb 6, 2026.
Get emailed when insiders cluster-buy stocks like CING
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
CING insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | $657K | 5 | — | 0 |
Valuation, profit and volume
Summary
Over the past 12 months, 4 Cingulate Inc. insiders reported open-market purchases totaling $647K, while 0 insiders reported sales totaling $0. The most recent cluster buy began on Feb 6, 2026, when 4 insiders bought a combined $647K.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Jun 8SEC | Thomas Jeffrey HargrovesDirector | Buy | 97,27697,468 held (+50665%) | $5.04 | $490K | -3.0% | — |
| Feb 10SEC | Peter J. WerthDirector | Buy | 19,455117,449 held (+20%) | $5.04 | $98K | -3.0% | — |
| Feb 10SEC | Shane J. SchafferCEO | Buy | 6,80910,175 held (+202%) | $5.04 | $34K | -3.0% | — |
| Feb 10SEC | Jennifer L. CallahanCFO | Buy | 4,8645,059 held (+2494%) | $5.04 | $25K | -3.0% | — |
| Feb 10SEC | Matthew BramsEvp And Chief Medical Officer | Buy | 1,9464,656 held (+72%) | $5.04 | $10K | -3.0% | — |
Insiders at Cingulate Inc.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Thomas Jeffrey HargrovesDirector | $490K | — | Jun 8, 2026 | — |
| Peter J. WerthDirector | $98K | — | Feb 10, 2026 | — |
| Shane J. SchafferCEO | $34K | — | Feb 10, 2026 | — |
| Jennifer L. CallahanCFO | $25K | — | Feb 10, 2026 | — |
| Matthew BramsEvp And Chief Medical Officer | $10K | — | Feb 10, 2026 | — |
CING stock: common questions
Are Cingulate Inc. insiders buying CING stock?
In the past 12 months, 4 insiders reported open-market purchases of CING worth $647K. The latest was Director Thomas Jeffrey Hargroves bought $490K of CING at $5.04 — first open-market purchase in our records; raises the stake by 50665%.
Are Cingulate Inc. insiders selling CING stock?
0 insiders reported sales worth $0 over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is CING's 52-week range?
Over the past year CING has traded between $3.33 and $11.66. It last closed at $4.89 on Oct 9, 2026.